AAREYDRUGSBSEAarey Drugs & Pharmaceuticals LtdMinimalNeutral
Announced Fri, 29 May · 20:14 IST

Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve intimation regarding ....

AAREYDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.1%1-day move
₹77.50
prior close
₹77.99
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.2+3.3+3.9+1.9-2.1-1.9+0.0+1.3+2.9+2.9+13.3+14.0
Up moveDown movePending
AI summary

Aarey Drugs & Pharmaceuticals has informed BSE that its Board Meeting originally scheduled for Friday, 29th May, 2026 has been postponed and rescheduled to Saturday, 30th May, 2026 due to unavoidable circumstances. The meeting will consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2026, along with the Auditors' Report. The Trading Window for insiders remains closed and will reopen 48 hours after the financial results are announced.

Likely market impact

The one-day postponement is minor and unlikely to significantly impact the stock. However, the upcoming financial results approval for FY2026 could be a key catalyst for investors once announced.